Differential Diagnosis of Hypercalcemia: Laboratory Assessment

  • H. Schmidt-Gayk
  • Heike Haerdt
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 137)

Abstract

The differential diagnosis of hypercalcemia can be very simple in many cases as well as extremely complicated and difficult in others. Initially, the history of the patient is very important as well as a physical examination and X-rays, as described by Ziegler in this volume. The laboratory assessment is based on the routine serum and urine chemistry tests.

Keywords

Lithium Lymphoma Osteoporosis Cortisol Glucocorticoid 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahrén B, Bergenfelz A (1993) Potential clinical use of the EDTA-infusion test. Eur J Clin Chem Clin Biochem 31:353–358PubMedGoogle Scholar
  2. Birnbaum J, Klandorf H, Giuliano A, van Herle A (1988) Lithium stimulates the release of human parathyroid hormone in vitro. J Clin Endocrinol Metab 66: 1187–1191PubMedCrossRefGoogle Scholar
  3. Blind E, Schmidt-Gayk H, Armbruster FP, Stadler A (1987) Measurement of intact human parathyrin by an extracting two-site immunoradiometric assay. Clin Chem 33:1376–1381PubMedGoogle Scholar
  4. Blind E, Schmidt-Gayk H, Scharia S, Flentje D, Fischer S, Ghring U, Hitzler W (1988) Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay. J Clin Endocrinol Metab 67:353–360PubMedCrossRefGoogle Scholar
  5. Blind E, Flentje D, Fischer S (1990) Clinical application of intact parathyroid hormone determination. In: Schmidt-Gayk H, Armbruster FP, Bouillon R (eds) Calcium regulating hormones, vitamin D metabolites, and cyclic Amp, assays and their clinical application. Springer, Berlin Heidelberg New York, pp 3–23Google Scholar
  6. Blind E, Raue F, Reichel H (1992) Validity of intact plasma parathyrin measurements in chronic renal failure as determined by two-site immunoradiometric assays with N-or C-terminal capture antibodies. Clin Chem 38:2345–2347PubMedGoogle Scholar
  7. Blind E, Raue F, Meinel T, Bucher M, Manegold C, Ebert W, Vogt-Moykopf I, Ziegler R (1993) Levels of parathyroid hormone-related protein in hypercalcemia of malignancy: comparison of midregional radioimmunoassay and two-site immunoradiometric assay. Clin Invest 71:31–36CrossRefGoogle Scholar
  8. Bonnin MR, Gonzalez MT, Arranz B, Rosel P, Navarro MA (1988) Intact parathyrin in patients after kidney transplantation. Clin Chem 34:2378PubMedGoogle Scholar
  9. Bouillon R, De Moor P (1974) Parathyroid function in patients with hyper-or hypothyroidism. J Clin Endocrinol Metab 38:999–1004PubMedCrossRefGoogle Scholar
  10. Burman KD, Monchik JM, Earll JM, Wartofsky L (1976) Ionized and total serum calcium and parathyroid hormone in hyperthyroidism. Ann Intern Med 84: 668–671PubMedGoogle Scholar
  11. Burtis WJ, Brady TG, Orlof JJ, Ersbak JB, Warrell RP, Olson BR, Wu TL, Mitnick ME, Broadus AE, Stewart AF (1990) Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 322:1106–1112PubMedCrossRefGoogle Scholar
  12. Coen G, Bondatti F, de Matteis A, Ballanti P, Mazzaferro S, Sardella D, Smacchi A (1989) Severe vitamin D deficiency in a case of primary hyperparathyroidism caused by parathyroid lipoadenoma, effect of 25OHD3 treatment. Miner Electrolyte Metab 15:332–337PubMedGoogle Scholar
  13. David DS, Sakai S, Brennan L, Riggio RA, Cheigh J, Stenzel KH, Rubin AL, Sherwood LM (1973) Hypercalcemia after renal transplantation, long-term follow-up data. N Engl Med 289:398–401CrossRefGoogle Scholar
  14. Dexter RN, Mullinax F, Estep HL, Williams RC (1972) Monoclonal IgG gammopathy and hyperparathyroidism. Ann Intern Med 77:759–764PubMedGoogle Scholar
  15. Fair HW, Fahey TJ, Nash AG, Farr CM (1973) Primary hyperparathyroidism and cancer. Am J Surg 126:539–543CrossRefGoogle Scholar
  16. Fraser WD, Firek Ahren, Robinson Z, Lawton R, Durham B, Gallacher SZ, Boyle IT, Beastall GH, Logue FC (1993) Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related protein. Clin Chem 39:414–419PubMedGoogle Scholar
  17. Fuleihan GEH, Chen CJ, Rivkees SA, Marynick SP, Stock J, Pallotta JA, Brown EM (1989) Calcium-dependent release of N-terminal fragments and intact immunoreactive parathyroid hormone by human pathological parathyroid tissue in vitro. J Clin Endocrinol Metab 69:860–867CrossRefGoogle Scholar
  18. Gallacher SJ, Fraser WD, Logue FC, Dryburgh FJ, Cowan RA, Boyle IT, Ralston SH (1992) Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy. Calcif Tissue Int 51:419–423PubMedCrossRefGoogle Scholar
  19. Gallacher SJ, Fraser WD, Farquharson MA, Logue FC, McArdle C, Boyle IT, Nairn ER, McNicol AM (1993) Coincidental occurrence of primary hyperparathyroidism and cancer associated hypercalcemia in a middle-aged man. Clin Endocrinol 38:433–437CrossRefGoogle Scholar
  20. Harms HM, Kaptaina U, Kuelpmann WR, Brabant G, Hesch RD (1989) Pulse amplitude and frequency modulation of parathyroid hormone in plasma. J Clin Endocrinol Metab 69:843–851PubMedCrossRefGoogle Scholar
  21. Herfarth K, Schmidt-Gayk H, Graf S, Maier A (1992) Circadian rhythm and pulsatility of parathyroid hormone secretion in man. Clin Endocrinol 37:511–519CrossRefGoogle Scholar
  22. Hollenberg AN, Arnold A (1991) Hypercalcemia with low-normal serum intact PTH: a novel presentation of primary hyperparathyroidism. Am J Med 91: 547–548PubMedCrossRefGoogle Scholar
  23. Husdan H, Rapoport A, Locke S (1973) Influence of posture on the serum concentration of calcium. Metabolism 22:787–797CrossRefGoogle Scholar
  24. Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, Fuleihan GEH, Seely EW (1992) Hypervitaminosis D associated with drinking milk. N Engl J Med 326:1173–1177PubMedCrossRefGoogle Scholar
  25. Klee GG, Preissner CM, Schryver PG, Taylor RL, Kao PC (1992) Multisite immunochemiluminometric assay for simultaneously measuring whole-molecule and amino-terminal fragments of human parathyrin. Clin Chem 38:628–635PubMedGoogle Scholar
  26. Krause U, Zielke A, Schmidt-Gayk H, Ehrenthal W, Beyer J (1989) Direct tubular effect on calcium retention by hydrochlorothiazide. J Endocrinol Invest 12: 531–535PubMedGoogle Scholar
  27. LoCascio V, Adami S, Galvanini G, Ferrari M, Cominacini L, Tartarotti D (1985) Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism. N Engl J Med 313:1123–1125PubMedCrossRefGoogle Scholar
  28. Ljunghall S, Joborn H, Roxin LE, Skarfors ET, Wide LE, Lithell HO (1988) Increase in serum parathyroid hormone after prolonged exercise. Med Sci Sports Exerc 20:122–125PubMedCrossRefGoogle Scholar
  29. Mallette LE, Khouri K, Zengotita H, Hollis BW, Malini S (1989) Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume. J Clin Endocrinol Metab 68:654–660PubMedCrossRefGoogle Scholar
  30. Marx SJ, Stock JL, Attie MF, Downs RW, Gardner DG, Brown EM, Spiegel AM, Doppman JL, Brennan MF (1980) Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration. Ann Intern Med 92:351–356PubMedGoogle Scholar
  31. Marx SJ, Spiegel AM, Levine MA, Rizzoli RE, Lasker RD, Santora AC, Downs RW, Aurvach GD (1982) Familial hypocalciuric hypercalcemia, the relation to primary parathyroid hyperplasia. N Engl J Med 307:416–426PubMedCrossRefGoogle Scholar
  32. Marx SJ, Menczel J, Campbell G, Aurbach GD, Spiegel AM, Norton JA (1991) Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1. Clin Endocrinol 35:521–526CrossRefGoogle Scholar
  33. McElduff A, Lackmann M, Wilkinson M (1992) Antiidiotypic PTH antibodies as a cause of elevated immunoreactive parathyroid hormone in idiopathic hypoparathy roidism, a second case: another manifestation of autoimmune endocrine disease? Calcif Tissue Int 51:121–126PubMedCrossRefGoogle Scholar
  34. Meneghini LF, Oster JR, Camacho JR, Gkonos PJ, Roos BA (1993) Hypercalcemia in association with acute renal failure and rhabdomyolysis. Miner Electrolyte Metab 19:1–16PubMedGoogle Scholar
  35. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts JT jr, Segre GV (1987) Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364–1367PubMedGoogle Scholar
  36. Palmer FJ, Nelson JC, Bacchus H (1974) The chloride-phosphate ratio in hypercalcemia. Ann Intern Med 80:200–204PubMedGoogle Scholar
  37. Pandian MR, Morgan CH, Carlton E, Segre GV (1992) Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia. Clin Chem 38:282–288PubMedGoogle Scholar
  38. Parfitt AM (1969) Chlorothiazide-induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. N Engl J Med 281:55–59PubMedCrossRefGoogle Scholar
  39. Paterson CR (1980) Vitamin-D poisoning: survey of causes in 21 patients with hypercalcemia. Lancet 1:1164–1165PubMedCrossRefGoogle Scholar
  40. Payne RB, Carver ME, Morgan DB (1979) Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol 32:56–60PubMedCrossRefGoogle Scholar
  41. Reeves CD, Palmer F, Bacchus H, Longerbeam JK (1975) Differential diagnosis of hypercalcemia by the chloride/phosphate ratio. Am J Surg 130:166–171PubMedCrossRefGoogle Scholar
  42. Rosenthal N, Insogna KL, Godsall JW, Smaldone L, Waldron JA, Stewart AF (1985) Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab 60:29–33PubMedCrossRefGoogle Scholar
  43. Schilling T, Pecherstorfer M, Blind E, Leidig G, Ziegler R, Raue F (1993) Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. J Clin Endocrinol Metab 76: 801–803PubMedCrossRefGoogle Scholar
  44. Schmidt-Gayk H, Stengel R, Haueisen H, Huefner M, Ritz E, Jakobs KH (1977) Hyperparathyroidism: influence of glomerular filtration rate on urinary excretion of cyclic AMP. Klin Wschr 55:275–281PubMedCrossRefGoogle Scholar
  45. Schmidt-Gayk H, Radeck H, Haerdt H (1991) Erfassung von Stoerungen des Calciumund Phosphatstoffwechsels, der Nierenfunktion und der Ernaehrung: Programm für IBM-kompatible Personal-Computer. Nieren Hochdruckkrankht 20:678–684Google Scholar
  46. Segre V (1990) Advances in techniques for measurement of parathyroid hormone, current applications in clinical medicine and directions for future research. Trends Endocrinol Metab (TEM) 243–247Google Scholar
  47. Seelig MS (1970) Hyperreactivity to vitamin D. Med Counterpoint 2:28–44Google Scholar
  48. Shane E (1993) Hypercalcemia: pathogenesis, clinical manifestations, and differential diagnosis. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 2nd edn. Raven, New York, pp 153–155Google Scholar
  49. Shaw NJ, Wheeldon J, Brocklebank JT (1992) The tubular maximum for calcium reabsorption: a normal range in children. Clin Endocrinol 36:193–195CrossRefGoogle Scholar
  50. Solal MEC, Sebert JL, Boudailliez B, Marie A, Moriniere P, Gueris J, Bouillon R, Fournier A (1991) Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 73:516–524PubMedCrossRefGoogle Scholar
  51. Streeten EA, Weinstein LS, Norton JA, Mulvihill JJ, White BJ, Friedman E, Jaffe G, Brandi ML, Stewart K, Zimering MB, Spiegel AM, Aurbach GD, Marx SJ (1992) Studies in a kindred with parathyroid carcinoma. J Clin Endocrinol Metab 75:362–366PubMedCrossRefGoogle Scholar
  52. Szabo J, Khosla S, Heath H III (1993) Familial hyperparathyroid syndromes. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 2nd edn. Raven, New York, pp 164–166Google Scholar
  53. Thome JF, Bilezikian JP, Clemens TL, Silverberg SJ, Shane E, Lindsay R (1990) Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism. J Clin Endocrinol Metab 70: 951–956CrossRefGoogle Scholar
  54. Vieth R (1990) The mechanisms of vitamin D toxicity. Bone Miner 11:267–272PubMedCrossRefGoogle Scholar
  55. Vosik WM, Anderson CF, Steffee WP, Johnson WJ, Arnaud CD, Goldsmith RS (1972) Successful medical management of osteitis fibrosa due to “tertiary” hyperparathyroidism. Mayo Clin Proc 47:110–113PubMedGoogle Scholar
  56. Wilkinson M, McElduff A, Wilson J, Haber P, Freeman A, Robertson M, Mathews P (1990) Spontaneously occurring antibodies to parathyroid hormone. J Clin Endocrinol Metab 70:1744–1749PubMedCrossRefGoogle Scholar
  57. Yoshimoto K, Yamasaki R, Sakai H, Tezuka U, Takahashi M, Iizuka M, Sekiya T, Saito S (1989) Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 68:976–981PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • H. Schmidt-Gayk
    • 1
  • Heike Haerdt
    • 1
  1. 1.Laboratory GroupHeidelbergGermany

Personalised recommendations